Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research

The article, “Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research,” explores a growing trend to reduce reliance on animal testing in rare disease research. This shift, driven by health regulators in the US, is aimed at accelerating the development of treatments for rare diseases while improving accuracy and reducing ethical concerns. Emerging alternatives to traditional preclinical models are highlighted as game-changing innovations, offering more relevant and efficient testing pathways.